Phase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors.
第一作者:
Srivandana,Akshintala
第一单位:
Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
作者:
主题词
投药, 口服(Administration, Oral);青少年(Adolescent);抗肿瘤药(Antineoplastic Agents);脑肿瘤(Brain Neoplasms);儿童(Child);儿童, 学龄前(Child, Preschool);DNA修复(DNA Repair);剂量效应关系, 药物(Dose-Response Relationship, Drug);女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);男(雄)性(Male);最大耐受剂量(Maximum Tolerated Dose);有机铂化合物(Organoplatinum Compounds);青年人(Young Adult)
DOI
10.1002/pbc.25344
PMID
25556988
发布时间
2025-05-29
- 浏览53
Pediatric blood & cancer
603-10页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



